Welcome to Pentamed – Leaders in Advanced Surgical Solutions
Founded in 2012, and listed in 2022 in HKEX (Stock Code: 2172.HK.) MicroPort® NeuroTech has been at the forefront of neurovascular care. Our comprehensive neuro-interventional devices portfolio encompasses three key domains: hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke (AIS). With 196+ authorized patents and a presence in over 2800 hospitals, our commitment to innovation is resolute. Our products facilitate more than 100 cerebrovascular stenting procedures daily. At MicroPort® NeuroTech, our mission is to deliver accessible, top-quality, and comprehensive solutions for stroke patients globally. We are dedicated to pushing the boundaries of neuro-interventional care, aiming for better and longer lives for patients around the world.
Intracranial aneurysm
Intracranial aneurysm is not a solid tumor, but an abnormal topical bulge in the arterial wall caused by abnormal vascular changes, which is the weakest part of the vessel wall. Aneurysms may rupture and bleed under the impact of blood flow and changes in blood pressure. Due to the atypical symptoms before rupture but dangerous and rapid development of the disease after rupture, many patients die before they are sent to the hospital in time. This makes aneurysm a real invisible killer. It is also known as a “time bomb” in the intracranial cavity.
